Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
Status:
Terminated
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the feasibility, safety and tolerability of aerosolized lucinactant delivered by
nasal continuous positive airway pressure (nCPAP) for the prevention of respiratory distress
syndrome (RDS) in premature infants.